Denis Getsios

1.5k total citations
51 papers, 1.2k citations indexed

About

Denis Getsios is a scholar working on Economics and Econometrics, Psychiatry and Mental health and Geriatrics and Gerontology. According to data from OpenAlex, Denis Getsios has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Economics and Econometrics, 12 papers in Psychiatry and Mental health and 9 papers in Geriatrics and Gerontology. Recurrent topics in Denis Getsios's work include Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical Practices and Patient Outcomes (9 papers) and Pharmaceutical Economics and Policy (9 papers). Denis Getsios is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (21 papers), Pharmaceutical Practices and Patient Outcomes (9 papers) and Pharmaceutical Economics and Policy (9 papers). Denis Getsios collaborates with scholars based in United States, Canada and United Kingdom. Denis Getsios's co-authors include J. Jaime, Kristen Migliaccio–Walle, Alexandra Ward, K. Jack Ishak, Jörgen Möller, Judith A. O’Brien, Grant Maclaine, Steve Blume, Krista K. Payne and George Papadopoulos and has published in prestigious journals such as PLoS ONE, Neurology and BMC Public Health.

In The Last Decade

Denis Getsios

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denis Getsios United States 21 495 307 245 167 152 51 1.2k
Roman Casciano United States 19 251 0.5× 59 0.2× 214 0.9× 37 0.2× 46 0.3× 68 859
Raymond J. Townsend United States 18 302 0.6× 347 1.1× 155 0.6× 101 0.6× 6 0.0× 46 1.2k
Shahrul Mt‐Isa United Kingdom 19 251 0.5× 60 0.2× 102 0.4× 54 0.3× 9 0.1× 52 1.3k
Sally E. McNagny United States 15 125 0.3× 28 0.1× 139 0.6× 35 0.2× 51 0.3× 17 775
David D. Dore United States 18 109 0.2× 120 0.4× 177 0.7× 158 0.9× 5 0.0× 65 1.5k
Marianne Cunnington United Kingdom 17 47 0.1× 605 2.0× 262 1.1× 25 0.1× 57 0.4× 34 1.3k
Antonio Segura Spain 18 101 0.2× 44 0.1× 131 0.5× 33 0.2× 19 0.1× 34 1.2k
Viktoria Gloy Switzerland 21 106 0.2× 54 0.2× 249 1.0× 50 0.3× 12 0.1× 42 2.1k
Isabelle Arnet Switzerland 19 174 0.4× 222 0.7× 69 0.3× 359 2.1× 10 0.1× 89 1.2k
Shu Chuen Li Australia 22 179 0.4× 85 0.3× 202 0.8× 243 1.5× 3 0.0× 61 1.2k

Countries citing papers authored by Denis Getsios

Since Specialization
Citations

This map shows the geographic impact of Denis Getsios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Getsios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Getsios more than expected).

Fields of papers citing papers by Denis Getsios

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Getsios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Getsios. The network helps show where Denis Getsios may publish in the future.

Co-authorship network of co-authors of Denis Getsios

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Getsios. A scholar is included among the top collaborators of Denis Getsios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Getsios. Denis Getsios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrières, Jean, Jean Dallongeville, Michel Rossignol, et al.. (2016). Model-observational bridging study on the effectiveness of ezetimibe on cardiovascular morbidity and mortality in France: A population-based study. Journal of clinical lipidology. 10(6). 1379–1388. 2 indexed citations
2.
Hernández, Luis, et al.. (2016). Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer’s Disease. PharmacoEconomics. 34(7). 681–707. 13 indexed citations
3.
4.
Guo, Shien, et al.. (2014). Evaluating Disease-Modifying Agents: A Simulation Framework for Alzheimer’s Disease. PharmacoEconomics. 32(11). 1129–1139. 19 indexed citations
5.
Getsios, Denis, Jenő P. Marton, Alexandra Ward, et al.. (2013). Smoking Cessation Treatment and Outcomes Patterns Simulation: A New Framework for Evaluating the Potential Health and Economic Impact of Smoking Cessation Interventions. PharmacoEconomics. 31(9). 767–780. 19 indexed citations
6.
Ishak, K. Jack, Marilyn Stolar, Ming‐yi Hu, et al.. (2012). Accounting for the relationship between per diem cost and LOS when estimating hospitalization costs. BMC Health Services Research. 12(1). 439–439. 20 indexed citations
7.
Coudeville, Laurent, Annelies Van Rie, Denis Getsios, et al.. (2009). Adult Vaccination Strategies for the Control of Pertussis in the United States: An Economic Evaluation Including the Dynamic Population Effects. PLoS ONE. 4(7). e6284–e6284. 55 indexed citations
8.
Maclaine, Grant, Denis Getsios, Steve Blume, & Jack Ishak. (2009). P3‐224: Updated cost‐effectiveness projections for donepezil in the treatment of patients with mild‐to‐moderately severe Alzheimer's disease in the UK. Alzheimer s & Dementia. 5(4S_Part_13).
9.
Jaime, J., et al.. (2007). Invasive meningococcal disease epidemiology and control measures: a framework for evaluation. BMC Public Health. 7(1). 130–130. 18 indexed citations
10.
O’Brien, Judith A., J. Jaime, & Denis Getsios. (2006). Managing Meningococcal Disease in the United States: Hospital Case Characteristics and Costs by Age. Value in Health. 9(4). 236–243. 21 indexed citations
11.
Jaime, J., Denis Getsios, Krista K. Payne, et al.. (2005). Economic Burden of Pertussis and the Impact of Immunization. The Pediatric Infectious Disease Journal. 24(5). S48–S54. 27 indexed citations
12.
Getsios, Denis, et al.. (2005). Pharmacological Management of Overactive Bladder. PharmacoEconomics. 23(10). 995–1006. 15 indexed citations
13.
Jaime, J., et al.. (2005). Pertussis Immunization of Adolescents in the United States. The Pediatric Infectious Disease Journal. 24(5). S75–S82. 50 indexed citations
14.
Getsios, Denis, et al.. (2004). Oxybutynin Extended Release and Tolterodine Immediate Release. Clinical Drug Investigation. 24(2). 81–88. 10 indexed citations
15.
Jaime, J., Maribel Salas, Alexandra Ward, et al.. (2004). Assessing the Health and Economic Impact of Galantamine Treatment in Patients with Alzheimer???s Disease in the Health Care Systems of Different Countries. Drugs & Aging. 21(10). 677–686. 20 indexed citations
16.
Ward, Alexandra, Denis Getsios, Judith A. O’Brien, & J. Jaime. (2004). Economic assessments of low molecular weight heparin in venous thromboembolism. Expert Review of Pharmacoeconomics & Outcomes Research. 4(1). 39–47.
18.
Getsios, Denis, et al.. (2002). Instituting a routine varicella vaccination program in Canada: an economic evaluation. The Pediatric Infectious Disease Journal. 21(6). 542–547. 24 indexed citations
19.
Jaime, J., et al.. (2002). Cost Effectiveness of Tinzaparin Sodium Versus Unfractionated Heparin in the Treatment of Proximal Deep Vein Thrombosis. PharmacoEconomics. 20(9). 593–602. 21 indexed citations
20.
O’Brien, Judith A., et al.. (2001). Diabetes in Canada: Direct Medical Costs of Major Macrovascular Complications. Value in Health. 4(3). 258–265. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026